Elevated Gal-3 levels have been associated with worse clinical outcomes in HF patients, but its independent prognostic value and clinical utility relative to established biomarkers, such as natriuretic peptides and soluble suppression of tumorigenicity-2 (sST2), remain debated [3]. Here, LGALS3 is linked to hydrops fetalis.